Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 48   

Articles published

NIPT 25.17 -0.83 (-3.18%)
price chart
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company, But Struggles To Sell Energy Unit  London South East
Related articles »  
PEG Ratio (5 yr expected):
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
Premaitha Health PLC Price Target Raised to GBX 31 (NIPT)
Premaitha Health PLC logo Panmure Gordon raised their target price on shares of Premaitha Health PLC (LON:NIPT) from GBX 28 ($0.41) to GBX 31 ($0.46) in a research note issued on Monday.
Research Analysts' Price Target Changes for March, 16th (AFAM, AFR, AML ...  Mideast Time
Illumina Files Patent Infringement Suit in the United Kingdom Against ...
SAN DIEGO, Mar 16, 2015 (BUSINESS WIRE) -- Illumina, Inc. ILMN, +1.22% today announced that it and its wholly-owned subsidiary, Verinata Health Inc., (together �Illumina�) have filed a patent infringement suit against Premaitha Health plc in the High ...
Esperite (ESP) and Premaitha Health sign a collaboration agreement for NIPT ...  Nasdaq
SMALL CAP IDEAS: Premaitha Health builds foundations for successful ...
Very often investors are asked to commit to the long haul when they buy into the latest new thing in the healthcare sector. With Premaitha Health the serious commercial groundwork is already underway as the diagnostics firm is ready to go to market ...
Premaitha Health PLC (Formerly ViaLogy PLC) ("Premaitha" or the "Company ...
LONDON, UNITED KINGDOM--(Marketwired - Jul 4, 2014) - Premaitha Health PLC ( LSE : NIPT). Admission to AIM. Premaitha's Admission and trading of its Ordinary Shares on AIM commences at 08.00hrs today (TIDM: NIPT).
Related articles »  
Premaitha Health PLC's "Buy" Rating Reiterated at Panmure Gordon (VIY)
Premaitha Health PLC logo Panmure Gordon reissued their buy rating on shares of Premaitha Health PLC (LON:VIY) in a research note released on Tuesday morning.
Panmure Gordon Reaffirms "Buy" Rating for Premaitha Health PLC (VIY)
Shares of Premaitha Health PLC (LON:VIY) traded up 9656.098% during mid-day trading on Tuesday, hitting GBX 0.205. The stock had a trading volume of 294,514,114 shares.
Panmure Gordon Reiterates "Buy" Rating for Premaitha Health PLC (VIY)
Premaitha Health PLC logo Premaitha Health PLC (LON:VIY)'s stock had its �buy� rating reaffirmed by equities researchers at Panmure Gordon in a research report issued on Tuesday.
BRIEF-Esperite and Premaitha Health sign a collaboration agreement for NIPT ...
March 16 (Reuters) - Esperite N.V. : * Signs a collaboration agreement with Premaitha Health PLC for NIPT provision in Europe.